Literature DB >> 2978742

Response of atrial natriuretic peptide to adrenaline and noradrenaline infusion in man.

T J Tunny1, A W Bachmann, R D Gordon.   

Abstract

1. Atrial natriuretic peptide (ANP) levels were significantly increased during both adrenaline and noradrenaline infusions, in the physiological range, in normal subjects and in patients with essential hypertension. 2. During adrenaline infusion significant increases in both circulating adrenaline and noradrenaline levels were observed. Mean arterial pressure was unaltered. Changes in heart rate were not significant. 3. During noradrenaline infusion, significant increases in circulating noradrenaline and mean arterial pressure were also observed. Heart rate and plasma adrenaline levels were unaltered. 4. Fluctuations in sympathetic nervous system activity may be involved in the regulation of ANP via adrenoceptor stimulated release of ANP. Other known regulators such as atrial stretch and increasing heart rate may modify this response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2978742     DOI: 10.1111/j.1440-1681.1988.tb01077.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Elevation of plasma atrial natriuretic peptide occurs during adrenaline infusion in hypertensive but not normotensive subjects.

Authors:  T J Tunny; R D Gordon; A W Bachmann; S A Klemm
Journal:  Clin Auton Res       Date:  1992-10       Impact factor: 4.435

2.  Alpha-Adrenergic Mechanisms in the Cardiovascular Hyperreactivity to Norepinephrine-Infusion in Essential Hypertension.

Authors:  Lisa-Marie Walther; Roland von Känel; Nadja Heimgartner; Claudia Zuccarella-Hackl; Guido Stirnimann; Petra H Wirtz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

3.  Effect of adrenaline on serum mid-regional pro-atrial natriuretic peptide and central blood volume.

Authors:  Casper Sejersen; Jonathan J Bjerre-Bastos; Jens P Goetze; Henning B Nielsen; Asger R Bihlet; Niels H Secher
Journal:  Exp Physiol       Date:  2022-08-21       Impact factor: 2.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.